Article
Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis.
Molecular genetics and metabolism - 1 Aug 2011
Wang Guo-li, Wang Jing, Douglas Ganka, Browning Marsha, Hahn Sihoun, Ganesh Jaya, Cox Sarah, Aleck Kirk, Schmitt Eric S, Zhang Wei, Wong Lee-Jun C
Abstract excerpt
Carnitine-acylcarnitine translocase (CACT) deficiency is a rare autosomal recessive disease of fatty acid oxidation, mainly affecting long chain fatty acid utilization. The disease usually presents at neonatal period with severe hypoketotic hypoglycemia, hyperammonemia, cardiomyopathy and/or arrhythmia, hepatic dysfunction, skeletal muscle weakness, and encephalopathy. Definitive diagnosis of CACT deficiency by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
